Bronchiolitis
SR Dalziel, L Haskell, S O'Brien, ML Borland, AC Plint… - The Lancet, 2022 - thelancet.com
Viral bronchiolitis is the most common cause of admission to hospital for infants in high-
income countries. Respiratory syncytial virus accounts for 60–80% of bronchiolitis …
income countries. Respiratory syncytial virus accounts for 60–80% of bronchiolitis …
Role of viruses in asthma
T Jartti, K Bønnelykke, V Elenius… - Seminars in …, 2020 - Springer
Respiratory viral infections are the most important triggers of asthma exacerbations.
Rhinovirus (RV), the common cold virus, is clearly the most prevalent pathogen constantly …
Rhinovirus (RV), the common cold virus, is clearly the most prevalent pathogen constantly …
Hospital admissions and need for mechanical ventilation in children with respiratory syncytial virus before and during the COVID-19 pandemic: a Danish nationwide …
U Nygaard, UB Hartling, J Nielsen… - The Lancet Child & …, 2023 - thelancet.com
Background The incidence of respiratory syncytial virus (RSV) increased in several
countries after the relaxation of COVID-19 restrictions. We aimed to investigate the age …
countries after the relaxation of COVID-19 restrictions. We aimed to investigate the age …
Considerations on biologicals for patients with allergic disease in times of the COVID‐19 pandemic: an EAACI statement
The outbreak of the SARS‐CoV‐2‐induced coronavirus disease 2019 (COVID‐19)
pandemic re‐shaped doctor‐patient interaction and challenged capacities of healthcare …
pandemic re‐shaped doctor‐patient interaction and challenged capacities of healthcare …
[HTML][HTML] Trained immunity induction by the inactivated mucosal vaccine MV130 protects against experimental viral respiratory infections
P Brandi, L Conejero, FJ Cueto, S Martínez-Cano… - Cell Reports, 2022 - cell.com
MV130 is an inactivated polybacterial mucosal vaccine that confers protection to patients
against recurrent respiratory infections, including those of viral etiology. However, its …
against recurrent respiratory infections, including those of viral etiology. However, its …
Bacterial mucosal immunotherapy with MV130 prevents recurrent wheezing in children: a randomized, double-blind, placebo-controlled clinical trial
A Nieto, A Mazón, M Nieto, R Calderón… - American Journal of …, 2021 - atsjournals.org
Rationale: Recurrent wheezing in children represents a severe public health concern.
Wheezing attacks (WA), mainly associated with viral infections, lack effective preventive …
Wheezing attacks (WA), mainly associated with viral infections, lack effective preventive …
Cytokines in the respiratory airway as biomarkers of severity and prognosis for respiratory syncytial virus infection: an update
Y Vázquez, L González, L Noguera… - Frontiers in …, 2019 - frontiersin.org
The human respiratory syncytial virus (hRSV) is one of the most important causes of upper
and lower respiratory tract infections in children and the main cause of bronchiolitis …
and lower respiratory tract infections in children and the main cause of bronchiolitis …
Rhinovirus type in severe bronchiolitis and the development of asthma
E Bergroth, M Aakula, V Elenius, S Remes… - The Journal of Allergy …, 2020 - Elsevier
Background Respiratory syncytial virus (RSV)-and rhinovirus (RV)-induced bronchiolitis are
associated with an increased risk of asthma, but more detailed information is needed on …
associated with an increased risk of asthma, but more detailed information is needed on …
[HTML][HTML] Abnormal airway mucus secretion induced by virus infection
Y Li, XX Tang - Frontiers in immunology, 2021 - frontiersin.org
The airway mucus barrier is a primary defensive layer at the airway surface. Mucins are the
major structural components of airway mucus that protect the respiratory tract. Respiratory …
major structural components of airway mucus that protect the respiratory tract. Respiratory …
[HTML][HTML] Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic: position paper of Ärzteverband Deutscher …
L Klimek, O Pfaar, M Worm, T Eiwegger… - Allergologie …, 2020 - ncbi.nlm.nih.gov
Background: Since the beginning of the COVID-19 pandemic, the treatment of patients with
allergic and atopy-associated diseases has faced major challenges. Recommendations for …
allergic and atopy-associated diseases has faced major challenges. Recommendations for …